Evidence map›Paper›PMID 42891487›Full record

ArticleAdvanced biomedical research2026

Impact of Ocular Residual Astigmatism on Visual and Refractive Outcomes Following Photorefractive Keratectomy.

Alireza Peyman, Amir Sadeghi, Mohammad Ghoreishi, Ali-Akbar Mortazavi, Pegah Noorshargh, Mohsen Pourazizi

Abstract read
In one paragraph

Article in Advanced biomedical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alireza PeymanIsfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
Amir SadeghiIsfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohammad GhoreishiParsian Vision Science Research Institute, Isfahan, Iran.
Ali-Akbar MortazaviIsfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
Pegah NoorsharghIsfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.
Mohsen PouraziziIsfahan Eye Research Center, Department of Ophthalmology, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The aim of the study was to evaluate the impact of ocular residual astigmatism (ORA) on refractive and visual outcomes following photorefractive keratectomy (PRK) in myopic astigmatism patients. Materials and Methods: This analytical cross-sectional study was performed on patients who underwent PRK. Patients were evaluated for refractive error, visual acuity, and keratometry before and six months after surgery. To calculate the ORA, vectorial differences between corneal plane refractive astigmatism and keratometric astigmatism were established. Results: Two hundred and six eyes from 206 patients including 117 females (56.8%), with a mean age of 32.32 ± 7.03 years were enrolled. The mean ORA was 0.79 ± 0.35 D. There was a negative correlation between cylinder magnitude (r = -0.24, Conclusion: We found comparable visual outcomes between eyes with low and high ORA that were treated with PRK. Patients with ATR astigmatism had more ORA and the success of astigmatism surgery was lower in patients with a higher ORA.

Indexed as

Astigmatismphotorefractive keratectomyrefractive errorsrefractive surgical procedures

Identifiers

PMID42891487
PMCPMC13675042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.